Search results
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
The Boston Globe· 6 days agoModerna’s stock dropped 45 percent last year, making it the worst-performing large biotech in the...
Novavax Stock Just Tripled. Is It Too Late to Buy?
The Motley Fool via AOL· 13 hours agoToday, Pfizer and Moderna dominate the coronavirus vaccine market, making it difficult for a smaller player to gain much share, but an alliance with a...
AstraZeneca pulls its COVID-19 vaccine from the European market
seattlepi.com· 7 days agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
Moderna: FDA Extends RSV Vaccine Review, But No Issues Flagged
Morningstar· 5 days agoThe company said the FDA cited administrative constraints for the delay, and that the agency is working to complete its review of mRNA-1345 by the end of the month. Moderna
Merit Financial Group LLC Lowers Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 7 days agoMerit Financial Group LLC lowered its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 19.1% in the 4th quarter, according to its most recent 13F filing with the SEC ...
Moderna says FDA delaying decision on RSV vaccine approval, shares fall
Investing.com· 6 days agoModerna says FDA delaying decision on RSV vaccine approval, shares fall
Moderna says FDA delaying decision on RSV vaccine approval
Stars and Stripes· 6 days agoUS regulators’ decision on whether to approve Moderna Inc.’s vaccine for RSV has been delayed due to...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks· 3 days agoFree Report) were down 4.4% on May 10 after the company announced that the FDA has delayed the review timeline for its mRNA-based, respiratory syncytial virus (RSV) vaccine
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 6 days agoOther nations' regulatory bodies followed suit. The rest, as they say, is history. Pandemic-prompted...
FDA delays decision date for Moderna's RSV vaccine - Boston Business Journal
The Business Journals· 5 days agoJust days before its deadline, the U.S. Food and Drug Administration says it's giving itself more...